Human Medicines European Public Assessment Report (EPAR): Briviact (In Italy: Nubriveo), Brivaracetam, Epilepsy, Date of Authorisation: 13/01/2016, Revision: 6, Status: Authorised

Case Medical Research
doi 10.31525/cmr-11ef042
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy